Development of therapeutic systems to treat the infarcted heart
Cardiovascular disease is the leading cause of morbidity and mortality in developed nations, and heart disease is predicted to remain the leading killer for the foreseeable future. Acute myocardial infarctions—nearly 1.1 million annually occurring in the U.S. alone—are the major cardiovascular disea...
Main Author: | |
---|---|
Other Authors: | |
Format: | Others |
Language: | en_US |
Published: |
Georgia Institute of Technology
2015
|
Subjects: | |
Online Access: | http://hdl.handle.net/1853/53429 |
id |
ndltd-GATECH-oai-smartech.gatech.edu-1853-53429 |
---|---|
record_format |
oai_dc |
spelling |
ndltd-GATECH-oai-smartech.gatech.edu-1853-534292015-06-27T03:39:48ZDevelopment of therapeutic systems to treat the infarcted heartGray, Warren DaleMyocardial infarctionCardiac protectionCardiac regenerationAngiogenesisTherapeutic systemNanoparticleDendrimerExosomeHypoxiaN-acetylglucosamineCardiovascular disease is the leading cause of morbidity and mortality in developed nations, and heart disease is predicted to remain the leading killer for the foreseeable future. Acute myocardial infarctions—nearly 1.1 million annually occurring in the U.S. alone—are the major cardiovascular disease subgroup. Current treatments for myocardial infarction are limited to interventions that serve to mitigate the initial insult, but clinical applications to protect or regenerate damaged myocardium are lacking. This dissertation examines three therapeutic systems to treat the infarcted heart. First, the decoration of a polymeric nanoparticle with N-acetylglucosamine for the uptake of anti-apoptotic therapeutics to ameliorate cardiomyocyte cell death. Second, novel dendrimeric structure architecture to allow for regioselected decoration of ligands to induce angiogenesis. Third, exosomes secreted from hypoxic cardiac progenitor cells as a naturally derived therapeuticfor angiogenesis and anti-fibrosis, and to provide bio-inspired clues for future therapies.Georgia Institute of TechnologyLuo, YingDavis, Michael E.2015-06-08T18:10:56Z2015-06-08T18:10:56Z2014-052014-03-25May 20142015-06-08T18:10:56ZDissertationapplication/pdfhttp://hdl.handle.net/1853/53429en_US |
collection |
NDLTD |
language |
en_US |
format |
Others
|
sources |
NDLTD |
topic |
Myocardial infarction Cardiac protection Cardiac regeneration Angiogenesis Therapeutic system Nanoparticle Dendrimer Exosome Hypoxia N-acetylglucosamine |
spellingShingle |
Myocardial infarction Cardiac protection Cardiac regeneration Angiogenesis Therapeutic system Nanoparticle Dendrimer Exosome Hypoxia N-acetylglucosamine Gray, Warren Dale Development of therapeutic systems to treat the infarcted heart |
description |
Cardiovascular disease is the leading cause of morbidity and mortality in developed nations, and heart disease is predicted to remain the leading killer for the foreseeable future. Acute myocardial infarctions—nearly 1.1 million annually occurring in the U.S. alone—are the major cardiovascular disease subgroup. Current treatments for myocardial infarction are limited to interventions that serve to mitigate the initial insult, but clinical applications to protect or regenerate damaged myocardium are lacking. This dissertation examines three therapeutic systems to treat the infarcted heart. First, the decoration of a polymeric nanoparticle with N-acetylglucosamine for the uptake of anti-apoptotic therapeutics to ameliorate cardiomyocyte cell death. Second, novel dendrimeric structure architecture to allow for regioselected decoration of ligands to induce angiogenesis. Third, exosomes secreted from hypoxic cardiac progenitor cells as a naturally derived therapeuticfor angiogenesis and anti-fibrosis, and to provide bio-inspired clues for future therapies. |
author2 |
Luo, Ying |
author_facet |
Luo, Ying Gray, Warren Dale |
author |
Gray, Warren Dale |
author_sort |
Gray, Warren Dale |
title |
Development of therapeutic systems to treat the infarcted heart |
title_short |
Development of therapeutic systems to treat the infarcted heart |
title_full |
Development of therapeutic systems to treat the infarcted heart |
title_fullStr |
Development of therapeutic systems to treat the infarcted heart |
title_full_unstemmed |
Development of therapeutic systems to treat the infarcted heart |
title_sort |
development of therapeutic systems to treat the infarcted heart |
publisher |
Georgia Institute of Technology |
publishDate |
2015 |
url |
http://hdl.handle.net/1853/53429 |
work_keys_str_mv |
AT graywarrendale developmentoftherapeuticsystemstotreattheinfarctedheart |
_version_ |
1716806550601859072 |